Business & Tech
Mallinckrodt Signs Distribution Deal with Amneal
It is a three-year distribution agreement for a generic version of Suboxone, a medicine used to treat opioid addiction.
Hazelwood based Mallinckrodt Pharmaceuticals has shaken hands on a deal with Amneal Pharmaceuticals to distribute medications to addiction treatment centers.
The Covidien spinoff, which claimed its independence this summer, will ensure Buprenorphine HCl and Naloxone HCl Dihydrate two a generic version of Suboxone, a medication used to help with opioid dependence, makes it to clinics for the next three years.
There is an option to extend written into the agreement. Mallinckrodt is a major supplier of generic opioid dependence products to U.S. addiction treatment centers, according to a company statement.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
The contract amount of the dealt was not released.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
We’ve removed the ability to reply as we work to make improvements. Learn more here